6190
PhoenixBio Co.,Ltd.
フェニックスバイオ
- Industry
- Services
- Market
- Growth
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Key metrics
Revenue(thousand JPY)
Mar 2021
1,013,543
Mar 2022
1,324,817
Mar 2023
2,124,051
Mar 2024
1,715,321
Mar 2025
1,541,388
Operating profit(thousand JPY)
Mar 2021
-276,889
Mar 2022
-167,619
Mar 2023
508,448
Mar 2024
11,063
Mar 2025
-142,079
Operating profit margin(%)
Mar 2021
-27.32
Mar 2022
-12.65
Mar 2023
23.94
Mar 2024
0.64
Mar 2025
-9.22
Profit before tax(thousand JPY)
Mar 2021
-223,875
Mar 2022
-393,002
Mar 2023
510,644
Mar 2024
59,785
Mar 2025
-432,841
Profit(thousand JPY)
Mar 2021
-238,002
Mar 2022
-387,970
Mar 2023
493,329
Mar 2024
26,378
Mar 2025
-448,933
Total assets(thousand JPY)
Mar 2021
2,516,324
Mar 2022
2,280,467
Mar 2023
3,018,661
Mar 2024
2,715,320
Mar 2025
2,285,342
Cash and cash equivalents(thousand JPY)
Mar 2021
1,327,813
Mar 2022
1,325,507
Mar 2023
1,555,323
Mar 2024
1,384,891
Mar 2025
1,149,390
Cash flows from operating activities(thousand JPY)
Mar 2021
-101,909
Mar 2022
16,398
Mar 2023
277,491
Mar 2024
-79,307
Mar 2025
-73,000
Cash flows from investing activities(thousand JPY)
Mar 2021
-184,775
Mar 2022
-6,975
Mar 2023
-156,340
Mar 2024
115,358
Mar 2025
-27,985
Cash flows from financing activities(thousand JPY)
Mar 2021
-160,194
Mar 2022
-34,658
Mar 2023
86,630
Mar 2024
-244,879
Mar 2025
-128,000
Return on equity(%)
Mar 2021
-
Mar 2022
-
Mar 2023
42.41
Mar 2024
1.61
Mar 2025
-
Equity ratio(%)
Mar 2021
43.45
Mar 2022
36.12
Mar 2023
49.79
Mar 2024
65.67
Mar 2025
59.11
Earnings per share(JPY per share)
Mar 2021
-73.6
Mar 2022
-117.5
Mar 2023
145.23
Mar 2024
6.98
Mar 2025
-110.99
Net assets per share(JPY per share)
Mar 2021
332.47
Mar 2022
249.05
Mar 2023
413.63
Mar 2024
442.65
Mar 2025
333.49
Dividend per share(-)
Mar 2021
-
Mar 2022
-
Mar 2023
-
Mar 2024
-
Mar 2025
-
Payout ratio(-)
Mar 2021
-
Mar 2022
-
Mar 2023
-
Mar 2024
-
Mar 2025
-
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.